<div id="readability-page-1"><p>In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Talphera, with a price target of <span id="expert-recommendation-target">$3.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Rahman covers the Healthcare sector, focusing on stocks such as Talphera, Kazia Therapeutics, and Vivani Medical. According to TipRanks, Rahman has an average return of <span>-9.3%</span> and a 33.33% success rate on recommended stocks. </p> <p>In a report released today, Alliance Global Partners also maintained a Buy rating on the stock with a $3.50 price target.</p></div>

TLPH

<p>Maxim Group's Naz Rahman reiterated a Buy rating on Talphera with a $3.00 price target. Alliance Global Partners also maintained a Buy rating with a $3.50 target. Rahman, focusing on healthcare stocks, has an average return of -9.3% and a 33.33% success rate. The report highlights investment insights on Talphera.</p>

Maxim Group Remains a Buy on Talphera (TLPH)